There will be more CR. Most likely the CR will be done after CE...

There will be more CR.
Most likely the CR will be done after CE approval.
Page 4 of Half yearly reports and accounts.

" The Company intends to raise A$7.7 million now with a combination of placements and an Entitlement Issue available to all shareholders, and anticipates targeting a further A$15 – 22 million later this year from international strategic investors to: o Complete final EMA review, to seek approval for CE Mark and proceed with targeted country sales launches in the EU and internationally; o Fund an FDA diabetic ulcer clinical trial to start during the second half of 2015. This clinical trial is expected to take 24 months and cost US$10 million; and o Provide working capital."